ctrl K

Watchlist Price Alert

Clarus Therapeutics Inc. (CRXT)

NASDAQ: CRXT · Real-Time Price · USD

0.05

-0.02 (-27.54%)

At close: Sep 06, 2022, 7:59 PM

Clarus Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2021	FY 2020
Period Ending	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	26.41M	655.37K
Short-Term Investments	n/a	58.65M
Long-Term Investments	n/a	n/a
Other Long-Term Assets	n/a	58.65M
Receivables	6.34M	n/a
Inventory	14.21M	n/a
Other Current Assets	4.67M	n/a
Total Current Assets	51.64M	823.51K
Property-Plant & Equipment	65K	n/a
Goodwill & Intangibles	n/a	n/a
Total Long-Term Assets	65K	58.65M
Total Assets	51.71M	59.47M
Account Payables	13.95M	178.65K
Deferred Revenue	1.58M	n/a
Short-Term Debt	42.27M	n/a
Other Current Liabilities	8.26M	242.2K
Total Current Liabilities	66.06M	420.85K
Long-Term Debt	n/a	n/a
Other Long-Term Liabilities	1.57M	18.71M
Total Long-Term Liabilities	1.57M	18.71M
Total Liabilities	67.63M	19.13M
Total Debt	42.27M	n/a
Common Stock	2K	35.34M
Retained Earnings	-321.65M	-148.03K
Comprehensive Income	-51.71M	n/a
Shareholders Equity	-15.92M	40.34M
Total Investments	n/a	58.65M